Screener > Sectoral / Thematic > PGIM India Healthcare Fund

PGIM India Healthcare Fund - Regular Plan - Growth Option

Compare with Peers →
AMC: PGIM India Mutual Fund • Category: Sectoral / Thematic • NAV: Rs 12.46 (2026-11-11) • Rank: #101 in category (#427 overall) • Index Proxy: Nifty 500
🛡️ Lower Volatility 🦺 Crash Buffer ⭐ Consistent Alpha 🚀 High Bull Capture
Information only. Past performance does not guarantee future returns. Check the scheme documents and consult a qualified professional before investing.

💡 Why Pick This Fund? Quantitative Strengths & Watch-outs

🟢 Key Strengths
  • Strong capital defense: downside capture of 64% limits losses during market corrections.
  • Generated +19.4% annualized alpha (excess return) over its benchmark.
🟡 Things to Keep in Mind
  • Limited historical track record under 3 years; long-term cycle performance is still evolving.
₹83₹94₹105₹116₹127Dec '24Dec '25Nov '26
PGIM India Healthcare Fund
Proxy (Nifty 500)

Key Statistics vs Category Median

Fund Size
Rs 152 cr
Category: Rs 804 cr (small)
Total Expense (TER)
2.65%
Category Median: 2.52%
Base Expense (BER)
2.10%
Excludes levies & brokerage
Sharpe Ratio
1.32
Category Median: 0.34
Beta
0.56
Category Median: 0.97
Alpha
+19.42%
Category Median: +1.89%
Standard Deviation
13.06%
Category Median: 16.05%
MFIQ Score
7.9/10
Good
Solid risk-adjusted returns and competitive cost profile within its category.
Returns (30%) 9.8/10
1Y return 24.9% against category median 3.9% (+21.0 points).
Risk Management (30%) 8.9/10
Sharpe ratio 1.32 (cat median 0.34), downside capture 63.6%, max fall -14.6%.
Consistency (20%) -/10
Under 3 years of consistency track record.
Cost Efficiency (20%) 3.4/10
Total expense ratio 2.65% vs category median 2.52% (+0.13% points).
Ranked #101 of 221 in Sectoral / Thematic. Percentile standing measured against category cohort.

Trailing Returns Comparison

Period Fund Return Category Median Difference
1 Month +7.04% +6.32% +0.72%
3 Months +1.88% -0.20% +2.08%
6 Months +15.91% +5.98% +9.93%
1 Year +24.85% +3.90% +20.95%
Since Inception +12.28% - -

Calendar Year Returns

Year Fund Category Median Gap
2026 +26.63% +4.03% +22.60%
2025 -2.67% +1.43% -4.10%

Daily Rolling Returns Summary

Rolling Window Minimum Average Median Maximum % Positive % Beating Proxy
1-Year Rolling -4.52% +11.45% +12.01% +26.48% 83.6% 69.5%

Risk Profile & Deepest Drawdowns

Sortino Ratio
2.00
Category: 0.46
R-Squared
0.397
Correlation with Proxy
Upside Capture
154.2%
Monthly return ratio
Downside Capture
63.6%
Lower is better

Deepest Market Corrections (Depth >= 10%)

Peak Date Trough Date Fall Depth Months to Bottom Recovery Period
2025-01-07 2025-02-28 -14.6% 2 months 14 months
2026-08-31 2026-10-23 -10.2% 2 months 1 months

Portfolio & Asset Allocation

Statutory Asset Allocation Mandate (SEBI / SID)

Instrument Category Permitted Allocation Range
Equity and equity related securities of pharmaceutical and healthcare companies- Min 80% and Max 100% Equity & Equity Related Securities of other companies- Min 0% and Max 20% Money Market Instruments and, other liquid instruments, Units of Liquid, Money Market and Overnight Mutual funds - Min 0% and Max 20% Units issued by InvITs - Min 0% and Max 10% Foreign securities including overseas ETFs - Min 0% and Max 20% Units of Gold ETFs & Silver ETFs - Min 0% and Max 20% Per Scheme Mandate

Investment Objective & Strategy

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.

ℹ️ Detailed monthly stock-level holdings for this scheme are updated periodically from asset management company statutory disclosures.

Fund Size Position

Currently managing Rs 152 cr (AMFI Daily Fund AUM as of 2026-11-11). Positioned as small relative to Sectoral / Thematic schemes.

Too Small Small Comfortable Stretched Strained

Fund Management

Anandha Padmanabhan Anjeneyan
Utsav Mehta
Vivek Sharma
Puneet Pal

Cost & Capital Gains Taxation

From April 2026 the total expense ratio includes brokerage, transaction costs and statutory levies on top of the base fee.

Applicable Tax Structure

Equity-oriented schemes: 20% short-term capital gains tax if sold within 12 months; 12.5% long-term capital gains tax on gains exceeding ₹1.25 lakh per financial year when held for more than 12 months.

Tax rules as of 23 July 2024. Verify before investing.

Closest Sectoral / Thematic Peers by Rank

Scheme Score 3Y Return Expense Downside Fund Size Compare
Kotak Healthcare Fund 7.5 - 2.49% 35.1% Rs 928 cr Compare →
BAJAJ FINSERV HEALTHCARE FUND 7.8 - 2.59% 54.9% Rs 443 cr Compare →
Samco Flexi Cap Fund 0.8 -4.37% 3.17% 150.0% Rs 235 cr Compare →
WhiteOak Capital Pharma and Heathcare Fund 7.7 - 2.70% 44.1% Rs 1,022 cr Compare →
SBI CONSUMPTION OPPORTUNITIES FUND 3.2 +4.24% 2.22% 122.5% Rs 2,581 cr Compare →

Frequently Asked Questions about PGIM India Healthcare Fund

What is the expense ratio of PGIM India Healthcare Fund?

PGIM India Healthcare Fund has a total expense ratio (TER) of 2.65% with a base expense ratio of 2.1%, compared to the Sectoral / Thematic category median of 2.52%.

Who manages PGIM India Healthcare Fund?

PGIM India Healthcare Fund is managed by Anandha Padmanabhan Anjeneyan.

What are the historical returns of PGIM India Healthcare Fund?

PGIM India Healthcare Fund has a 1-year return of +24.85%.

How large is PGIM India Healthcare Fund?

PGIM India Healthcare Fund manages assets of Rs 152 cr, placing it in the 'small' size band relative to Sectoral / Thematic peers.

How is PGIM India Healthcare Fund scored on MFIQ?

PGIM India Healthcare Fund holds an MFIQ Score of 7.9/10 (Good), based on a category percentile composite across returns, risk, consistency, and cost.

How risky is PGIM India Healthcare Fund?

PGIM India Healthcare Fund has an official SEBI riskometer rating of Very High. Over the analyzed period, its annualized standard deviation is 13.06% with a maximum historical drawdown of -14.58%.